SA-VCP anti-complement therapy (EndoProtech)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameSA-VCP anti-complement therapy (EndoProtech)
Drug Alias Nameanti-complement therapy (EndoProtech)Streptavidin vaccinia virus complement control protein therapy (EndoProtech)
ClassificationBiologics
Mechanisms of ActionComplement system proteins inhibitors
TargetsComplement system proteins
Therapy Area/IndicationsReperfusion Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEndoProtech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEndoProtech Inc
Active IndicationsN/A
Inactive IndicationsReperfusion Injury

Other Information

ATC CodeN/A
Related LinksN/A